pyrroles has been researched along with Kaposi Sarcoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bernd, C; Miles, S; Noy, A; Politsmakher, A; von Roenn, J | 1 |
| Arastéh, K; Hannah, A | 1 |
1 review(s) available for pyrroles and Kaposi Sarcoma
| Article | Year |
|---|---|
The role of vascular endothelial growth factor (VEGF) in AIDS-related Kaposi's sarcoma.
Topics: AIDS-Related Opportunistic Infections; Angiogenesis Inhibitors; Antiviral Agents; Endothelial Growth Factors; Enzyme Inhibitors; HIV-1; Humans; Indoles; Lymphokines; Neovascularization, Pathologic; Protein Isoforms; Protein-Tyrosine Kinases; Pyrroles; Receptor Protein-Tyrosine Kinases; Receptors, Growth Factor; Receptors, Mitogen; Receptors, Vascular Endothelial Growth Factor; Sarcoma, Kaposi; Skin Neoplasms; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2000 |
2 other study(ies) available for pyrroles and Kaposi Sarcoma
| Article | Year |
|---|---|
Fatal hepatorenal failure and thrombocytopenia with SU5416, a vascular endothelial growth factor Flk-1 receptor inhibitor, in AIDS-Kaposi's sarcoma.
Topics: Acquired Immunodeficiency Syndrome; Angiogenesis Inhibitors; Fatal Outcome; Humans; Indoles; Liver Failure; Male; Middle Aged; Pyrroles; Renal Insufficiency; Sarcoma, Kaposi; Skin Neoplasms | 2007 |
KS trial begins.
Topics: Acquired Immunodeficiency Syndrome; Angiogenesis Inhibitors; Clinical Trials, Phase II as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Indoles; Male; Multicenter Studies as Topic; Patient Selection; Pyrroles; Sarcoma, Kaposi; United States | 2000 |